Page 20 - Read Online

Page 10 of 12 Miller et al. Mini-invasive Surg 2021;5:24 https://dx.doi.org/10.20517/2574-1225.2021.25

DECLARATIONS
Authors’ contributions
Made substantial contributions to conception and design of the study and performed data acquisition and
interpretation: Miller BL, Lau CS, Pachorek M, Yuh B, Sam AP
Performed data acquisition, as well as provided administrative, technical, and material support: Miller BL,
Lau CS, Pachorek M

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2021.

REFERENCES
1. Chang SS, Bochner BH, Chou R, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO
Guideline. J Urol 2017;198:552-9. DOI PubMed PMC
2. Chang SS, Boorjian SA, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO Guideline. J Urol
2016;196:1021-9. DOI PubMed
3. Menon M, Hemal AK, Tewari A, et al. Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int
2003;92:232-6. DOI PubMed
4. Hu JC, Chughtai B, O'Malley P, et al. Perioperative outcomes, health care costs, and survival after robotic-assisted versus open radical
cystectomy: A National Comparative Effectiveness Study. Eur Urol 2016;70:195-202. DOI PubMed
5. Cai PY, Khan AI, Shoag JE, Scherr DS. Robotic radical cystectomy in the contemporary management of bladder cancer. Urol Clin
North Am 2021;48:45-50. DOI PubMed
6. Parekh DJ, Reis IM, Castle EP, et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer
(RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 2018;391:2525-36. DOI PubMed
7. Venkatramani V, Reis IM, Castle EP, et al. Predictors of recurrence, and progression-free and overall survival following open versus
robotic radical cystectomy: Analysis from the RAZOR trial with a 3-year followup. J Urol 2020;203:522-9. DOI PubMed PMC
8. Khan MS, Omar K, Ahmed K, et al. Long-term oncological outcomes from an early phase randomised controlled three-arm trial of
open, robotic, and laparoscopic radical cystectomy (CORAL). Eur Urol 2020;77:110-8. DOI PubMed
9. Bochner BH, Dalbagni G, Marzouk KH, et al. Randomized trial comparing open radical cystectomy and robot-assisted laparoscopic
radical cystectomy: Oncologic outcomes. Eur Urol 2018;74:465-71. DOI PubMed PMC
10. Parekh DJ, Messer J, Fitzgerald J, Ercole B, Svatek R. Perioperative outcomes and oncologic efficacy from a pilot prospective
randomized clinical trial of open versus robotic assisted radical cystectomy. J Urol 2013;189:474-9. DOI PubMed
11. Nix J, Smith A, Kurpad R, Nielsen ME, Wallen EM, Pruthi RS. Prospective randomized controlled trial of robotic versus open radical
cystectomy for bladder cancer: perioperative and pathologic results. Eur Urol 2010;57:196-201. DOI PubMed
12. Wijburg CJ, Michels CTJ, Hannink G, Grutters JPC, Rovers MM, Alfred Witjes J; RACE Study Group. Robot-assisted radical
cystectomy versus open radical cystectomy in bladder cancer patients: a multicentre comparative effectiveness study. Eur Urol
2021;79:609-18. DOI PubMed
13. Asil E, Canda AE, Atmaca AF, et al. Outcomes and complications of radical cystectomy with ileal conduit urinary diversion: A
comparison between open, semi-robotic and totally robotic surgery. Int J Med Robot 2021:e2221. DOI PubMed
14. Ip KL, Javier-DesLoges JF, Leung C, et al. Comparison of long-term outcomes in a 10-year experience of robotic cystectomy vs. open
cystectomy. J Robot Surg 2020. DOI PubMed